Evercore ISI analyst Jason Bandel raised the firm’s price target on NOV Inc. (NOV) to $19 from $15 and keeps an In Line rating on the shares. The firm updated its model following Q4 results
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
- NOV Inc. price target raised to $21 from $19 at Stifel
- NOV Inc. price target raised to $21 from $20 at Susquehanna
- NOV Inc. reports Q4 EPS (21c), consensus 25c
- NOV Inc. sees Q1 revenue down (3%)-(1%) from $2.1B a year ago, consensus $2.05B
- NOV Inc. upgraded to Equal Weight from Underweight at Barclays